Autoimmune thyroid diseases,autoimmune hepatitis,celiac disease and type 1 diabetes mellitus in pediatric systemic lupus erythematosus: Results from the CARRA Legacy Registry
Restricted accessResearch articleFirst published online December, 2020
Autoimmune thyroid diseases,autoimmune hepatitis,celiac disease and type 1 diabetes mellitus in pediatric systemic lupus erythematosus: Results from the CARRA Legacy Registry
Polyautoimmunity (PA) with systemic lupus erythematosus (SLE) is reported as a poor prognostic factor, but little is known about its effect in childhood-onset SLE (cSLE). We describe PA in cSLE within the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry and evaluate its association to lupus disease outcomes.
Methods
CARRA Legacy Registry is the largest pediatric rheumatology registry that collected data at enrollment and every 6 months thereafter. We describe the co-occurrence of selected autoimmune disorders (autoimmune thyroid diseases, autoimmune hepatitis, celiac disease and type 1 diabetes mellitus) in cSLE. To assess outcomes, we studied measures of lupus disease activity, complications, and patient’s quality of life (QoL). Comparisons by PA status were made using chi-square, Fisher’s exact test, two-sample t-tests, Wilcoxon rank sum tests, and mixed effects models as appropriate.
Results
1285 patients met the American College of Rheumatology criteria for SLE. Of those, 388 (30%) had data on comorbidity. The prevalence of PA was 8.8%. Patients with PA reported more hospitalizations and aggressive immunotherapy use. SLEDAI and PGA scores improved over time, but did not differ by PA status. No significant differences were found in QoL measures or their trajectory over time by PA status.
Conclusion
In cSLE, PA is associated with more hospitalizations and aggressive immunotherapy use. Although lupus disease activity improved over time, patients' QoL neither improved over time nor differed by having other autoimmune disease. Prospective, case-control, long-term follow-up studies on cSLE are needed to validate our results.
TuckerLBUribeAGFernandezM, et al.
Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus2008;
17: 314–322.
2.
FrancoJSAmaya-AmayaJMolano-GonzalezN, et al.
Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus.Clin Endocrinol2015;
83: 943–950.
3.
LiuYCLinWYTsaiMC and Fu LS.
Systemic lupus erythematosus and thyroid disease – experience in a single medical center in Taiwan. J Microbiol Immunol Infect2019;
52: 480–486.
4.
AikawaNEJesusAALiphausBL, et al.
Organ-specific autoantibodies and autoimmune diseases in juvenile systemic lupus erythematosus and juvenile dermatomyositis patients. Clin Exp Rheumatol2012;
30: 126–131.
5.
Rojas-VillarragaAToroCEEspinosaG, et al.
Factors influencing polyautoimmunity in systemic lupus erythematosus.Autoimmun Rev2010;
9: 229–232.
6.
SetoueDNPittaACFiorotFJ, et al.
Symptomatic polyautoimmunity at diagnosis of 1463 childhood-onset lupus: a Brazilian multicenter study. Autoimmun Rev2018;
17: 836–839.
7.
ParkDJChoCSLeeSHPark SH and Kim HY.
Thyroid disorders in Korean patients with systemic lupus erythematosus.Scand J Rheumatol1995;
24: 13–17.
8.
KakehasiAMDiasVNDuarteJELanna CCD and Carvalho MAPd.
Thyroid abnormalities in systemic lupus erythematosus: a study in 100 Brazilian patients. Rev Bra Reumatol2006;
46: 375–379.
9.
KumarKKoleAKKarmakarPS and Ghosh A.
The spectrum of thyroid disorders in systemic lupus erythematosus.Rheumatol Int2012;
32: 73–78.
10.
AlhomaidahDAlsagheirAAl-MayoufSM.Coexistence of endocrinopathies in children with rheumatic diseases.Int J Pediatr Adolesc Med2016;
3: 119–122.
11.
BeukelmanTKimuraYIlowiteNT, et al.
The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months. Pediatr Rheumatol Online J2017;
15: 30.
12.
TanEMCohenASFriesJF, et al.
The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum1982;
25: 1271–1277.
GladmanDDUrowitzMBGoldsmithCH, et al.
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum1997;
40: 809–813.
15.
SinghGAthreyaBHFriesJF and Goldsmith DP.
Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum1994;
37: 1761–1769.
16.
LinWYChangCLFuLSLin CH and Lin HK.
Systemic lupus erythematosus and thyroid disease: a 10-year study. J Microbiol Immunol Infect2015;
48: 676–683.
17.
AntonelliAFallahiPMoscaM, et al.
Prevalence of thyroid dysfunctions in systemic lupus erythematosus. Metabolism2010;
59: 896–900.
18.
CooperGSStroehlaBC.The epidemiology of autoimmune diseases. Autoimmun Rev2003;
2: 119–125.
19.
HershAOvon SchevenEYazdanyJ, et al.
Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum2009;
61: 13–20.
20.
Rojas-VillarragaAAmaya-AmayaJRodriguez-RodriguezAMantilla RD and Anaya JM.
Introducing polyautoimmunity: secondary autoimmune diseases no longer exist.Autoimmune Dis2012;
2012: 254319.
21.
EfeCPurnakTOzaslanE, et al.
Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases.Scand J Gastroenterol2011;
46: 732–737.
22.
Cárdenas-RoldanJRojas-VillarragaAAnayaJM.How do autoimmune diseases cluster in families? A systematic review and meta-analysis.BMC Med2013;
11: 73.
23.
MalagónCGomezMDPMosqueraC, et al.
Juvenile polyautoimmunity in a rheumatology setting.Autoimmun Rev2019;
18: 369–381.
24.
GolderVOoiJJYAntonyAS, et al.
Discordance of patient and physician health status concerns in systemic lupus erythematosus.Lupus2018;
27: 501–506.
25.
Elera-FitzcarraldCFuentesAGonzalezLABurgos PI, Alarcon GS and Ugarte-Gil MF.
Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventions.Expert Rev Clin Immunol2018;
14: 915–931.
26.
KuriyaBGladmanDDIbanezD and Urowitz MB.
Quality of life over time in patients with systemic lupus erythematosus.Arthritis Rheum2008;
59: 181–185.
27.
KleinRMoghadam-KiaSTaylorL, et al.
Quality of life in cutaneous lupus erythematosus.J Am Acad Dermatol2011;
64: 849–858.
28.
MonahanRCBeaart-van de VoordeLJJSteup-BeekmanGM, et al.
Neuropsychiatric symptoms in systemic lupus erythematosus: impact on quality of life.Lupus2017;
26: 1252–1259.
29.
AppenzellerSClarkeAEPanopalisPJoseph L, St Pierre Y and Li T.
The relationship between renal activity and quality of life in systemic lupus erythematosus.J Rheumatol2009;
36: 947–952.
30.
ChiaraTLindaCAndreaDS, et al.
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus.Curr Rheumatol Rev2018;
14: 188–192.
31.
AlarconGSMcGwinGJrUribeA, et al.
Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course.Arthritis Rheum2004;
51:465–474.
32.
KulczyckaLSysa-JedrzejowskaARobakE.Quality of life and satisfaction with life in SLE patients-the importance of clinical manifestations.Clin Rheumatol2010;
29:991–997.
33.
FranklynKLauCSNavarraSV, et al.
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).Ann Rheum Dis2016;
75:1615–1621.
34.
MoorthyLNBaldinoMEKurraV, et al.
Relationship between health-related quality of life, disease activity and disease damage in a prospective international multicenter cohort of childhood onset systemic lupus erythematosus patients.Lupus2017;
26:255–265.
35.
LevyDMPeschkenCATuckerLB, et al.
Association of health-related quality of life in childhood-onset systemic lupus erythematosus with ethnicity: results from a multiethnic multicenter Canadian cohort. Arthritis Care Res2014;
66: 1767–1774.
36.
Etchegaray-MoralesIMendez-MartinezSJimenez-HernandezC, et al.
Factors associated with health-related quality of life in Mexican lupus patients using the LupusQol. PLoS One2017;
12: e0170209.
37.
CarrFNNicassioPMIshimoriML, et al.
Depression predicts self-reported disease activity in systemic lupus erythematosus.Lupus2011;
20: 80–84.
38.
MoldovanIKatsarosECarrFN, et al.
The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort. Lupus2011;
20: 1285–1292.
39.
TamLSWongAMokVC, et al.
The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus.J Rheumatol2008;
35: 1038–1045.
40.
DonnellyCCunninghamNJonesJTJi L, Brunner HI and Kashikar-Zuck S.
Fatigue and depression predict reduced health-related quality of life in childhood-onset lupus. Lupus2018;
27: 124–133.
41.
MinaRKlein-GitelmanMSNelsonS, et al.
Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus.Lupus2015;
24: 191–197.
42.
PattersonSLSchmajukGJafriK, et al.
Obesity is independently associated with worse patient-reported outcomes in women with systemic lupus erythematosus. Arthritis Care Res2019;
71: 126–133.
43.
StudenicPStammTSmolenJS and Aletaha D.
Reliability of patient-reported outcomes in rheumatoid arthritis patients: an observational prospective study.Rheumatology (Oxford)2016;
55: 41–48.
44.
TamayoTFischer-BetzRBeerSWinkler-Rohlfing B and Schneider M.
Factors influencing the health related quality of life in patients with systemic lupus erythematosus: long-term results (2001–2005) of patients in the German Lupus Erythematosus Self-Help Organization (LULA Study).Lupus2010;
19: 1606–1613.
45.
GroenWUnalENorgaardM, et al.
Comparing different revisions of the Childhood Health Assessment Questionnaire to reduce the ceiling effect and improve score distribution: data from a multi-center European cohort study of children with JIA. Pediatr Rheumatol Online J2010;
8: 16.
46.
RupertoNRavelliAMigliavaccaD, et al.
Responsiveness of clinical measures in children with oligoarticular juvenile chronic arthritis. J Rheumatol1999;
26: 1827–1830.
47.
BodeRKKlein-GitelmanMSMillerMLLechman TS and Pachman LM.
Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence.Arthritis Rheum2003;
49: 7–15.
48.
HuberAMHicksJELachenbruchPA, et al.
Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group.J Rheumatol2001;
28: 1106–1111.
49.
FautrelBAltenRKirkhamB, et al.
Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis.Rheumatol Int2018;
38: 935–947.
50.
HanGMHanXF.Comorbid conditions are associated with emergency department visits, hospitalizations, and medical charges of patients with systemic lupus erythematosus. J Clin Rheumatol2017;
23: 19–25.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
